Halo Therapeutics halotherapeutics.com


Public lists: Pharma Startups (4732)

Halo Therapeutics is dedicated to the rapid development of breakthrough treatments for Duchenne muscular dystrophy (DMD) and other rare fibrotic diseases. HT-100, our initial product candidate, is based on halofuginone. HT-100 is a derivative of a naturally-occurring compound and has potent anti-fibrotic and muscle regenerative biological activity.

Halo Therapeutics is dedicated to the rapid development of breakthrough treatments for Duchenne muscular dystrophy (DMD) and other rare fibrotic diseases. HT-100, our initial product candidate, is based on halofuginone. HT-100 is a derivative of a ...Show all

Company (Alive / Active)

Phone: 617-431-7250

Fax:

275 Grove Street
Suite 2-400
Auburndale, 02466
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Halo Therapeutics $0.5M Nov 14, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Halo Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Composition and method for treating or preventing skeletal muscle fibrosis Sep 06, 2016 Application
Dosage forms of halofuginone and methods of use Mar 29, 2013 Application